Release Details

TARRYTOWN, N.Y.--(BUSINESS WIRE)--March 18, 2008--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Lehman Brothers Global Healthcare Conference on Thursday, March 20, 2008. The presentation will provide an overview of the Company and its clinical programs and is scheduled to be broadcast live on Thursday, March 20 at 11:15 a.m. Eastern Time. The session may be accessed through the Company's web site (www.regeneron.com on the Investor Relations page, under the Presentations heading) at the time of the presentation. An archived version of the presentation will be available after the live webcast through April 19, 2008. Additional information about Regeneron and recent news releases are available on the Regeneron worldwide web site at www.regeneron.com

Regeneron is an integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST^™ (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.

CONTACT: Regeneron Pharmaceuticals, Inc.
Charles Poole, 914-345-7640
Vice President, Investor Relations
charles.poole@regeneron.com
or
Laura Lindsay, 914-345-7800
Media Relations
laura.lindsay@regeneron.com

SOURCE: Regeneron Pharmaceuticals, Inc.